These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18236043)

  • 1. Abstracts of DC2007 the 5th International Meeting on Dendritic Cell Vaccination and other Strategies to Tip the Balance of the Immune System. July 16-18, 2007. Bamberg, Germany.
    Cancer Immunol Immunother; 2008 Feb; 57 Suppl 1(Suppl 1):S1-53. PubMed ID: 18236043
    [No Abstract]   [Full Text] [Related]  

  • 2. Dendritic cell vaccination and other strategies to tip the balance of the immune system : DC2007 5th International Meeting, July 16-18, Bamberg, Germany.
    Schaft N; Birkholz K; Hofmann C; Schmid M; Theiner G; Dörrie J
    Cancer Immunol Immunother; 2008 Jun; 57(6):913-28. PubMed ID: 18236041
    [No Abstract]   [Full Text] [Related]  

  • 3. Dendritic Vaccines--Fifth International Meeting. Dendritic cell vaccination and other strategies to tip the balance of the immune system. 16-18 July 2007, Bamberg, Germany.
    Gabrilovich D
    IDrugs; 2007 Oct; 10(10):699-702. PubMed ID: 17899486
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical application of dendritic cells in cancer vaccination therapy.
    Svane IM; Soot ML; Buus S; Johnsen HE
    APMIS; 2003; 111(7-8):818-34. PubMed ID: 12974783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine strategies for glioblastoma: progress and future directions.
    Jackson C; Ruzevick J; Brem H; Lim M
    Immunotherapy; 2013 Feb; 5(2):155-67. PubMed ID: 23413907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells as vectors for therapy.
    Banchereau J; Schuler-Thurner B; Palucka AK; Schuler G
    Cell; 2001 Aug; 106(3):271-4. PubMed ID: 11509176
    [No Abstract]   [Full Text] [Related]  

  • 7. Dendritic cell vaccination in patients with malignant gliomas: current status and future directions.
    de Vleeschouwer S; Rapp M; Sorg RV; Steiger HJ; Stummer W; van Gool S; Sabel M
    Neurosurgery; 2006 Nov; 59(5):988-99; discussioin 999-1000. PubMed ID: 17143233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of dendritic cell therapy for cancer: progress and challenges.
    Mantia-Smaldone GM; Chu CS
    BioDrugs; 2013 Oct; 27(5):453-68. PubMed ID: 23592406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8(+) T cell/regulatory T cells in tumour.
    Song S; Zhang K; You H; Wang J; Wang Z; Yan C; Liu F
    Clin Exp Immunol; 2010 Oct; 162(1):75-83. PubMed ID: 20735440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dendritic cell-based therapeutic vaccination for acute myeloid leukemia].
    Anguille S; Van Tendeloo V; Berneman Z
    Bull Cancer; 2012 Jun; 99(6):635-42. PubMed ID: 22641288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells and immunotherapy for cancer.
    Chang DH; Dhodapkar MV
    Int J Hematol; 2003 Jun; 77(5):439-43. PubMed ID: 12841381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells in vaccination therapies of human malignant disease.
    Reichardt VL; Brossart P; Kanz L
    Blood Rev; 2004 Dec; 18(4):235-43. PubMed ID: 15501552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of dendritic cells for the immunotherapy of tumors].
    Weise JB; Maune S; Kabelitz D; Heiser A
    HNO; 2005 Feb; 53(2):117-20. PubMed ID: 15657753
    [No Abstract]   [Full Text] [Related]  

  • 15. A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma.
    Poschke I; Lövgren T; Adamson L; Nyström M; Andersson E; Hansson J; Tell R; Masucci GV; Kiessling R
    Cancer Immunol Immunother; 2014 Oct; 63(10):1061-71. PubMed ID: 24993563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell vaccination and immune monitoring.
    Aarntzen EH; Figdor CG; Adema GJ; Punt CJ; de Vries IJ
    Cancer Immunol Immunother; 2008 Oct; 57(10):1559-68. PubMed ID: 18618110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells: still a promising tool for cancer immunotherapy.
    Aragoneses-Fenoll L; Corbí AL
    Clin Transl Oncol; 2007 Feb; 9(2):77-82. PubMed ID: 17329218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell activation kinetics and cancer immunotherapy.
    Bellone M; Camporeale A; Boni A
    J Immunol; 2004 Mar; 172(5):2727-8. PubMed ID: 14978067
    [No Abstract]   [Full Text] [Related]  

  • 19. Using magnetic resonance imaging to evaluate dendritic cell-based vaccination.
    Ferguson PM; Slocombe A; Tilley RD; Hermans IF
    PLoS One; 2013; 8(5):e65318. PubMed ID: 23734246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell-based immunotherapy in thyroid malignancies.
    Schott M; Scherbaum WA; Seissler J
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Sep; 4(3):245-51. PubMed ID: 15379726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.